[A case of pyoderma gangrenosum associated to bevacizumab, angiogenesis role in its etiology]
Farm Hosp
.
2021 Sep 30;45(6):340-341.
[Article in Spanish]
Authors
Iván Maray-Mateos
1
,
Cristina Álvarez-Asteinza
2
,
Mónica Carbajales-Álvarez
3
,
Ana Lozano-Blázquez
4
Affiliations
1
Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo. Spain.. ivanmaraymateos@gmail.com.
2
Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo. Spain.. cristina.alvarez.asteinza@gmail.com.
3
Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo. Spain.. mcarbajales_6@hotmail.com.
4
Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo. Spain... ivanmaraymateos@gmail.com.
PMID:
34806575
No abstract available
Publication types
Case Reports
MeSH terms
Bevacizumab / adverse effects
Humans
Pyoderma Gangrenosum* / chemically induced
Pyoderma Gangrenosum* / drug therapy
Substances
Bevacizumab